{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:12:45Z","timestamp":1773760365778,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jpba.2025.116882","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T17:57:13Z","timestamp":1744135033000},"page":"116882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Unique methotrexate polyglutamates distributions in peripheral blood mononuclear cells of rheumatoid arthritis patients: Development and validation of a UPLC-MS\/MS method"],"prefix":"10.1016","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-7905-0214","authenticated-orcid":false,"given":"Janani","family":"Sundaresan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marry","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerrit","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6725-6719","authenticated-orcid":false,"given":"Renske C.F.","family":"Hebing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maja","family":"Bulatovi\u0107-\u0106alasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"de Jonge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard A.","family":"Struys","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurits C.F.J.","family":"de Rotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.116882_bib1","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.3390\/ijms21103483","article-title":"Overview of dual-acting drug methotrexate in different neurological diseases, autoimmune pathologies and cancers","volume":"21","author":"Ko\u017ami\u0144ski","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2025.116882_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11926-023-01116-7","article-title":"Oral versus subcutaneous methotrexate in immune-mediated inflammatory disorders: an update of the current literature","volume":"25","author":"Vermeer","year":"2023","journal-title":"Curr. Rheuma Rep."},{"key":"10.1016\/j.jpba.2025.116882_bib3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drup.2016.06.004","article-title":"Folylpoly-\u03b3-glutamate synthetase: a key determinant of folate homeostasis and antifolate resistance in cancer","volume":"28","author":"Raz","year":"2016","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jpba.2025.116882_bib4","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1002\/art.24034","article-title":"Pharmacokinetics of oral methotrexate in patients with rheumatoid arthritis","volume":"58","author":"Dalrymple","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpba.2025.116882_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drup.2012.07.002","article-title":"Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance","volume":"15","author":"Gonen","year":"2012","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.jpba.2025.116882_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/nrrheum.2016.175","article-title":"Mechanism of action of methotrexate in rheumatoid arthritis, and the search for biomarkers","volume":"12","author":"Brown","year":"2016","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.jpba.2025.116882_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","article-title":"Methotrexate and its mechanisms of action in inflammatory arthritis","volume":"16","author":"Cronstein","year":"2020","journal-title":"Nat. Rev. Rheuma"},{"key":"10.1016\/j.jpba.2025.116882_bib8","first-page":"2532","article-title":"Antifolate resistance mediated by the multidrug resistance proteins MRP1 and MRP2","volume":"59","author":"Hooijberg","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.jpba.2025.116882_bib9","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1002\/art.38094","article-title":"Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis","volume":"65","author":"Blits","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpba.2025.116882_bib10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/annrheumdis-2013-203723","article-title":"Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in juvenile idiopathic arthritis patients","volume":"74","author":"\u0106alasan","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jpba.2025.116882_bib11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1136\/annrheumdis-2013-203725","article-title":"Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis","volume":"74","author":"De Rotte","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jpba.2025.116882_bib12","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1002\/art.22129","article-title":"Pharmacogenomic and metabolic biomarkers in the folate pathway and their association with methotrexate effects during dosage escalation in rheumatoid arthritis","volume":"54","author":"Dervieux","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jpba.2025.116882_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/14397595.2016.1208137","article-title":"Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate\u2013polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis","volume":"27","author":"Murosaki","year":"2017","journal-title":"Mod. Rheuma"},{"key":"10.1016\/j.jpba.2025.116882_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2016-000363","article-title":"Association of erythrocyte methotrexate-polyglutamate levels with the efficacy and hepatotoxicity of methotrexate in patients with rheumatoid arthritis: a 76-week prospective study","volume":"3","author":"Takahashi","year":"2017","journal-title":"RMD Open"},{"key":"10.1016\/j.jpba.2025.116882_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/bcp.15579","article-title":"A meta-analysis of methotrexate polyglutamates in relation to efficacy and toxicity of methotrexate in inflammatory arthritis, colitis and dermatitis","volume":"89","author":"van de Meeberg","year":"2023","journal-title":"Br. J. Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.116882_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2023.05.001","article-title":"Dynamics of human hematopoietic stem and progenitor cell differentiation to the erythroid lineage","volume":"123","author":"Schippel","year":"2023","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.jpba.2025.116882_bib17","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1002\/1097-0142(19811201)48:11<2427::AID-CNCR2820481115>3.0.CO;2-M","article-title":"The transport and accumulation of methotrexate in human erythrocytes","volume":"48","author":"Da Costa","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.jpba.2025.116882_bib18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/PL00008489","article-title":"Comparative analysis of methotrexate polyglutamates in lymphoblast preparations from bone marrow and blood, and the contribution of residual red blood cells","volume":"126","author":"Weigand","year":"2000","journal-title":"J. Cancer Res. Clin. Onc"},{"key":"10.1016\/j.jpba.2025.116882_bib19","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/futurepharmacol3040049","article-title":"Erythrocyte folyl polyglutamate synthetase activity profiling as a potential tool for the prediction of methotrexate efficacy and toxicity in rheumatoid arthritis","volume":"3","author":"Kumar","year":"2023","journal-title":"Future Pharmacol."},{"key":"10.1016\/j.jpba.2025.116882_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00273386","article-title":"Methotrexate pharmacokinetics in age-fractionated erythrocytes","volume":"18","author":"Schr\u00f8der","year":"1986","journal-title":"Cancer Chemother. Pharm."},{"key":"10.1016\/j.jpba.2025.116882_bib21","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1084\/jem.20170355","article-title":"The fate and lifespan of human monocyte subsets in steady state and systemic inflammation","volume":"214","author":"Patel","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jpba.2025.116882_bib22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/ard-2022-223398","article-title":"Pharmacokinetics of oral and subcutaneous methotrexate in red and white blood cells in patients with early rheumatoid arthritis: the methotrexate monitoring trial","volume":"82","author":"Hebing","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jpba.2025.116882_bib23","first-page":"94","article-title":"Carry-over in automatic analysers","volume":"6","author":"Broughton","year":"1984","journal-title":"J. Autom. Chem."},{"key":"10.1016\/j.jpba.2025.116882_bib24","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/clinchem\/46.10.1650","article-title":"Determination of S-Adenosylmethionine and S-Adenosylhomocysteine in Plasma and Cerebrospinal Fluid by Stable-Isotope Dilution Tandem Mass Spectrometry","volume":"46","author":"Struys","year":"2000","journal-title":"Clin. Chem."},{"key":"10.1016\/j.jpba.2025.116882_bib25","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1007\/s00216-012-6581-7","article-title":"Measuring methotrexate polyglutamates in red blood cells: a new LC-MS\/MS-based method","volume":"405","author":"Den Boer","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2025.116882_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.202300571","article-title":"Matrix effects demystified: strategies for resolving challenges in analytical separations of complex samples","volume":"46","author":"Williams","year":"2023","journal-title":"J. Sep Sci."},{"key":"10.1016\/j.jpba.2025.116882_bib27","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jpba.2025.116882_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/bcpt.14047","article-title":"Methotrexate accumulation in target intestinal mucosa and white blood cells differs from non-target red blood cells of patients with Crohn\u2019s disease","volume":"135","author":"van de Meeberg","year":"2024","journal-title":"Basic Clin. Pharm. Toxicol."},{"key":"10.1016\/j.jpba.2025.116882_bib29","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1007\/s00216-022-04186-1","article-title":"Quantitation of methotrexate polyglutamates in human whole blood, erythrocytes and leukocytes collected via venepuncture and volumetric absorptive micro-sampling: a green LC\u2013MS\/MS-based method","volume":"414","author":"Daraghmeh","year":"2022","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jpba.2025.116882_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02918494","article-title":"Lifespan of Lymphocytes","volume":"14","author":"Tough","year":"1995","journal-title":"Immunol. Res."},{"key":"10.1016\/j.jpba.2025.116882_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.31083\/j.jmcm.2020.02.007","article-title":"Expression profiling of ABC transporters in peripheral blood lymphocytes and monocyte-derived macrophages of rheumatoid arthritis patients","volume":"3","author":"Oerlemans","year":"2020","journal-title":"J. Mol. Clin. Med."},{"key":"10.1016\/j.jpba.2025.116882_bib32","doi-asserted-by":"crossref","first-page":"9641","DOI":"10.3390\/ijms24119641","article-title":"Methotrexate provokes disparate folate metabolism gene expression and alternative splicing in ex vivo monocytes and GM-CSF- and M-CSF-polarized macrophages","volume":"24","author":"Muller","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2025.116882_bib33","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/rheumatology\/keq216","article-title":"Red blood cell methotrexate polyglutamates emerge as a function of dosage intensity and route of administration during pulse methotrexate therapy in rheumatoid arthritis","volume":"49","author":"Dervieux","year":"2010","journal-title":"Rheumatology (Oxford)."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525002237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T20:20:42Z","timestamp":1753388442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525002237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":33,"alternative-id":["S0731708525002237"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116882","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unique methotrexate polyglutamates distributions in peripheral blood mononuclear cells of rheumatoid arthritis patients: Development and validation of a UPLC-MS\/MS method","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116882"}}